QOL OUTCOMES DURING LONG-TERM TREATMENT WITH DARIFENACIN FOR OVERACTIVE BLADDER (OAB): A 2-YEAR, OPEN-LABEL EXTENSION STUDY

被引：0
|
作者：
Young, Jay [1 ]
Lheritier, Karine [2 ]
Steel, Michael [3 ]
Dwyer, Peter [4 ]
机构：
[1] Orange Cty Urol Associates, Med Res Ctr, Laguna Woods, CA USA
[2] Novartis Pharma AG, Biostat, Basel, Switzerland
[3] Novartis Pharma AG, Clin Dev & Med Affairs, Basel, Switzerland
[4] Mercy Hosp Women, Urogynaecol, Melbourne, Vic, Australia
来源：
QUALITY OF LIFE RESEARCH | 2005年 / 14卷 / 09期
关键词：
D O I：
暂无
中图分类号：
R19 [保健组织与事业（卫生事业管理）];
学科分类号：
摘要：
P-36/1678
引用
收藏
页码：2036 / 2036
页数：1
相关论文
共 50 条
  • [21] Long-term efficacy and safety of mipomersen in patients with familial hypercholesterolaemia: 2-year interim results of an open-label extension
    Santos, Raul D.
    Duell, P. Barton
    East, Cara
    Guyton, John R.
    Moriarty, Patrick M.
    Chin, Wai
    Mittleman, Robert S.
    EUROPEAN HEART JOURNAL, 2015, 36 (09) : 566 - 575
  • [22] Long-Term Treatment with Apixaban in Patients with Atrial Fibrillation: Outcomes during the Open-Label Extension following AVERROES
    Benz, Alexander P.
    Eikelboom, John W.
    Yusuf, Salim
    Hohnloser, Stefan H.
    Kahl, Anja
    Beresh, Heather
    Balasubramanian, Kumar
    Healey, Jeff S.
    Connolly, Stuart J.
    THROMBOSIS AND HAEMOSTASIS, 2021, 121 (04) : 518 - 528
  • [23] Tofacitinib in patients with moderate to severe chronic plaque psoriasis: 2-year efficacy and safety in an open-label long-term extension study
    Paul, Carle
    Langley, Richard G.
    Valenzuela, Fernando
    Cather, Jennifer
    Gardner, Annie
    Proulx, James
    Tan, Huaming
    Wolk, Robert
    Kaur, Mandeep
    Rottinghaus, Scott
    JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2016, 74 (05) : AB278 - AB278
  • [24] Efficacy of long-term treatment with lurasidone in children and adolescents with bipolar depression: Interim analysis of a 2-year open-label study
    DelBello, M. P.
    Goldman, R.
    Tocco, M.
    Pikalov, A.
    Deng, L.
    Loebel, A.
    EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2019, 29 : S368 - S368
  • [25] Long-term treatment with lumasiran: final results from the phase 2 open-label extension study
    Frishberg, Yaacov
    Groothoff, Jaap W.
    Hulton, Sally-Anne
    Harambat, Jerome
    Hogan, Julien
    Anne-Laure, Sellier-Leclerc
    Hayes, Wesley
    Coenen, Martin
    Willey, Richard
    Gansner, John
    Magen, Daniella
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 2024, 39
  • [26] Long-term treatment with lumasiran: final results from the phase 2 open-label extension study
    Frishberg, Yaacov
    Groothoff, Jaap W.
    Hulton, Sally-Anne
    Harambat, Jerome
    Hogan, Julien
    Anne-Laure, Sellier-Leclerc
    Hayes, Wesley
    Coenen, Martin
    Willey, Richard
    Gansner, John
    Magen, Daniella
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 2024, 39 : I2390 - I2392
  • [27] Long-term safety of an extended-cycle oral contraceptive (Seasonate): A 2-year multicenter open-label extension trial
    Anderson, F. D.
    Gibbons, William
    Portman, David
    AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY, 2006, 195 (01) : 92 - 96
  • [28] LONG-TERM TREATMENT OF PARTIAL EPILEPSY WITH ESLICARBAZEPINE ACETATE: RESULTS OF A 1-YEAR OPEN-LABEL EXTENSION STUDY
    Guekht, A.
    Elger, C.
    Halasz, P.
    Maia, J.
    Almeida, L.
    Soares-da-Silva, P.
    EPILEPSIA, 2009, 50 : 106 - 106
  • [29] Long-term treatment with ganaxolone for seizures associated with CDKL5 deficiency disorder: 2-year open-label extension follow-up
    Bahi-Buisson, N.
    Olson, H.
    Pestana-Knight, E.
    Devinsky, O.
    Amin, S.
    Marsh, E.
    Aimetti, A.
    Miller, I.
    Hulihan, J.
    Demarest, S.
    EPILEPSIA, 2023, 64 : 158 - 158
  • [30] Long-term efficacy and safety of adalimumab in the treatment of active ankylosing spondylitis: Results of an open-label, 2-year trial
    Haibel, H.
    Brandt, H. C.
    Baraliakos, X.
    Rudwaleit, M.
    Listing, J.
    Braun, J.
    Kupper, H.
    Sieper, J.
    ANNALS OF THE RHEUMATIC DISEASES, 2006, 65 : 218 - 219
12345